These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16932592)

  • 1. Methylprednisolone and other confounders to spinal cord injury clinical trials.
    Sipski ML; Pearse DD
    Nat Clin Pract Neurol; 2006 Aug; 2(8):402-3. PubMed ID: 16932592
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylprednisolone in acute spinal cord injury: is there any other ethical choice?
    Rozet I
    J Neurosurg Anesthesiol; 2008 Apr; 20(2):137-9. PubMed ID: 18362777
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylprednisolone in acute spinal cord injury: a tarnished standard.
    Miller SM
    J Neurosurg Anesthesiol; 2008 Apr; 20(2):140-2. PubMed ID: 18362778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Methylprednisolone in the treatment of acute spinal cord injury has become more and more questioned].
    Kronvall E; Sayer FT; Nilsson OG
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1887-8, 1890. PubMed ID: 16044768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal cord injury.
    Wilkinson HA
    J Neurosurg; 2001 Jan; 94(1 Suppl):180-1. PubMed ID: 11147862
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical applications of pharmacologic therapies for spinal cord injury.
    Zeidman SM; Ling GS; Ducker TB; Ellenbogen RG
    J Spinal Disord; 1996 Oct; 9(5):367-80. PubMed ID: 8938604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological therapy after acute cervical spinal cord injury.
    Chappell ET
    Neurosurgery; 2002 Sep; 51(3):855-6; author reply 856. PubMed ID: 12229872
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effect of methylprednisolone on acute cervical spinal cord injury and its mechanism].
    Lv ZH; Zhao CB; Li RY; Zhang J
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):570. PubMed ID: 17767841
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status of clinical trials for acute spinal cord injury.
    Fehlings MG; Baptiste DC
    Injury; 2005 Jul; 36 Suppl 2():B113-22. PubMed ID: 15993112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone for the treatment of acute spinal cord injury: counterpoint.
    Fehlings MG; Wilson JR; Cho N
    Neurosurgery; 2014 Aug; 61 Suppl 1():36-42. PubMed ID: 25032529
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylprednisolone for the treatment of acute spinal cord injury: point.
    Hurlbert RJ
    Neurosurgery; 2014 Aug; 61 Suppl 1():32-5. PubMed ID: 25032528
    [No Abstract]   [Full Text] [Related]  

  • 12. New drugs for improving injury outcome in spinal cord injuries.
    Werner PC
    West J Med; 1997 Apr; 166(4):271-2. PubMed ID: 9168687
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological management of acute spinal cord injury.
    Sharma A
    J Assoc Physicians India; 2012 May; 60 Suppl():13-8. PubMed ID: 23155791
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: recommendations regarding the use of methylprednisolone in acute spinal cord injury: making sense out of the controversy.
    Fehlings MG
    Spine (Phila Pa 1976); 2001 Dec; 26(24 Suppl):S56-7. PubMed ID: 11805611
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroprotection after spinal cord injury: state of the science.
    Segatore M; Way C
    SCI Nurs; 1997 Mar; 14(1):8-18. PubMed ID: 9165951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential benefits of high-dose methylprednisolone in acute spinal cord injuries.
    Walsh KA; Weant KA; Cook AM
    Orthopedics; 2010 Apr; 33(4):249-52. PubMed ID: 20415351
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylprednisolone after spinal cord injury.
    Segatore M; Way C
    SCI Nurs; 1993 Mar; 10(1):8-14. PubMed ID: 8484108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of postinjury intravenous or intrathecal methylprednisolone on spinal cord excitatory amino-acid release, nitric oxide generation, PGE2 synthesis, and myeloperoxidase content in a pig model of acute spinal cord injury.
    Bernards CM; Akers T
    Spinal Cord; 2006 Oct; 44(10):594-604. PubMed ID: 16432531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for neuroprotection following spinal cord injury.
    Tederko P; Krasuski M; Kiwerski J; Nyka I; Białoszewski D
    Ortop Traumatol Rehabil; 2009; 11(2):103-10. PubMed ID: 19502667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research advances in the application of methylprednisolone in the treatment of acute spinal cord injury.
    Kong XY; Gao J; Yang Y; Li YN; Ma WB; Xing B; Wang RZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Dec; 36(6):680-5. PubMed ID: 25556746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.